Pharmaceutical Supplier – FDA-Compliant Generic Drug Manufacturer

The contract involves the supply of FDA-approved Moxifloxacin Hydrochloride Tablets, 400 mg, ensuring strict adherence to federal pharmaceutical regulations, current Good Manufacturing Practices (cGMP), and specific military packaging and labeling standards. The procurement is managed by the Department of Defense under the Medical Supply Chain Pharm FSA, with performance designated at the FPO location, zip code 96678. This subcontract, associated with NAICS code 325412, targets a supplier capable of providing generic pharmaceuticals compliant with rigorous federal and military quality requirements. The solicitation was posted on May 11, 2026, with a response deadline of May 18, 2026, emphasizing a timely procurement process. While no specific set-aside designation or agency contact is provided, the contract link directs interested parties to the Defense Logistics Agency’s bidding system for further details. This underscores the government's intent to source high-quality, FDA-compliant generic drug manufacturers to support military pharmaceutical needs efficiently.